Continuing its expansion of healthcare services, Amazon India launched an at-home lab testing service called “Amazon Home Diagnostics” on June 22, 2025, as mentioned on its official website, About Amazon India (Official Press Release). Through this new service, customers can book lab tests, schedule sample collection, track reports, and receive digital reports right from their mobile.
It has been three years since Amazon launched its medicine delivery service through “Amazon Pharmacy.” Six months ago, it began offering virtual doctor consultations through “Amazon Clinic.”
When Amazon launched its new home diagnostics service, the share prices of major diagnostic companies like Dr. Lal PathLabs, Metropolis, Thyrocare, Krishna Diagnostics, and Suraksha Diagnostics fell, according to Trade Brains.
It will now allow users to book lab tests, schedule sample collection, track reports, and receive digital reports right from their mobile. The service, launched in collaboration with Orange Health Labs, will initially cover over 450 pincodes across six major cities — Bengaluru, Delhi, Gurgaon, Noida, Mumbai, and Hyderabad, ET HealthWorld (The Economic Times Health) explained.
According to Amazon Home Diagnostics, the services will offer:
- · Convenience to patients with speed, reliability, and easy service initiation
- · Sample collection at the doorstep within 60 minutes
- · Digital reports available within 6 hours
- · Access to over 800 diagnostic tests
- · Availability seven days a week
Notably, the Andy Jassy-led company made a $12 million investment in Orange Health in December last year through its Amazon Sambhav Venture Fund. At the time, the Bengaluru-based healthtech company was looking to grow its team, expand its product portfolio, and drive further innovation in diagnostics. With this, Amazon is completing its “trinity” of healthcare services — Amazon Pharmacy, Amazon Clinic, and now Amazon Diagnostics. The move has intensified competition and has led to a drop in the share prices of other companies in the diagnostics space.
India’s diagnostics industry has grown at a compound annual growth rate (CAGR) of 8% over the past five years, reaching a value of $12 billion (INR 1,200 crore) by 2023–24. The organized segment within this sector is growing at a faster rate of 12% CAGR, currently holding a market share of 15%. According to PhillipCapital Research, the sector is projected to grow at a CAGR of 14% in the coming years.
While many online diagnostic companies initially attracted customers with attractive discounts, there has now been a stabilization in market pricing.
According to experts:
- The penetration of diagnostic services is still very low—only 6% of the overall healthcare market.
- “The burden of non-communicable diseases such as heart, diabetes, or kidney diseases is increasing. These require regular testing.”
- The prevention and diagnosis market currently stands at 12% and is expected to grow further in the coming years.
The lack of accredited laboratories in rural areas and the prevalence of frequent misdiagnoses can be addressed. Experts believe there is an opportunity to build a more organized diagnostics service sector in India, and that consolidation is likely to increase in the future.
